Enovis (ENOV) vs Tandem Diabetes Care (TNDM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Tandem Diabetes Care (TNDM) has outperformed Enovis (ENOV) over the past year, gaining 2.2% versus a loss of 45.2%. Over five years, ENOV leads with a -80.0% price change compared with -87.5% for TNDM. Tandem Diabetes Care is the larger company by market cap ($1.12 billion vs $1.02 billion), about 1.1 times the size.
On valuation, Enovis trades at a lower forward P/E (4.9x vs 101.3x for Tandem Diabetes Care).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ENOV | TNDM |
|---|---|---|
| Share price | $17.69 | $16.11 |
| Market cap | $1.02B | $1.12B |
| 1-day change | +1.49% | +2.78% |
| YTD return | -34.57% | -28.69% |
| 1-year return | -45.15% | +2.18% |
| 5-year return | -79.99% | -87.50% |
| Forward P/E | 4.93 | 101.35 |
| EPS (TTM) | $-19.23 | $-0.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $34.28 | $29.65 |
| 52-week low | $16.70 | $12.26 |
| Distance from 52-week high | -48.40% | -45.67% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +112.44% | +72.94% |
| Average volume | 1.46M | 2.01M |
| Shares outstanding | 57.67M | 69.58M |
| Employees | 7,802 | 2,500 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TNDM has outperformed ENOV by 47.3 percentage points over the past year.
About Enovis
ENOV stock →Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.
Health Care · Industrial Specialties · 7,802 employees
About Tandem Diabetes Care
TNDM stock →Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
Health Care · Medical/Dental Instruments · 2,500 employees
ENOV vs TNDM FAQ
Which is bigger, Enovis or Tandem Diabetes Care?
Tandem Diabetes Care (TNDM) is larger, with a market capitalization of $1.12B compared with $1.02B for Enovis (ENOV).
Which stock has performed better over the past year, ENOV or TNDM?
TNDM returned +2.18% over the past 12 months, compared with -45.15% for ENOV (price return, excluding dividends). Past performance does not predict future results.
Are Enovis and Tandem Diabetes Care in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Enovis and Medical/Dental Instruments for Tandem Diabetes Care.